March 2013 - Page 2 of 17

WednesdayMar 27, 2013 2:56 pm

The Aristocrat Group Corp. (ASCC) Seeks Unique Approach in Billion-Dollar Flavored Vodka Market

In the past few years, an abundance of flavored vodkas have hit the market, from cotton candy to licorice and even bubble gum. In order to make a splash in the billion-dollar global flavored vodka market, though, the Aristocrat Group Corp. is targeting spirits tailored to the needs of mixologists, not drinkers. “Most of the new vodka flavors you’ll find at the bar or liquor store are either sickeningly sweet or just plain gimmicky,” said ASCC CEO Robert Federowicz. “They’re meant to capitalize on a trend, not survive in a competitive marketplace. Our approach to flavored vodka will be different.”…

WednesdayMar 27, 2013 2:38 pm

SmallCapVoice: Marley Coffee (JAMN) Available in P.C. Richard and Son Stores

Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, announced that their Real Cups, which are compatible with Keurig’s branded single serve K-cup machines, will become available at all 66 P.C. Richard & Son stores the first week of April. Commonly know as P.C. Richard, it is the largest chain of private, family-owned electronics and appliances stores in the United States, with locations throughout New York, New Jersey, Connecticut and Pennsylvania. Marley Coffee will be introducing 3 skus in a 24 pack put on special display units at all of the P.C. Richard and Sons. Get Up,…

WednesdayMar 27, 2013 1:46 pm

Catalyst Pharmaceutical Partners, Inc. (CPRX) Receives Recommendation from Data Monitoring Committee Regarding Phase III Clinical Trial of Firdapse

Today, specialty pharmaceutical company Catalyst Pharmaceutical Partners announced that the independent data monitoring committee (DMC) overseeing its ongoing pivotal Phase III clinical trial of Firdapse recommended on March 25 that the company continue the trial as planned based on the committee’s review of safety and clinical data from the trial. Firdapse is currently being evaluated in the United States and Europe to treat Lambert-Easton Myasthenic Syndrome (LEMS). The DMC is comprised of experts who are responsible for independently reviewing accumulated clinical safety and efficacy data obtained in Catalyst’s clinical trial, for the safety of participants and future patients. The committee…

WednesdayMar 27, 2013 10:49 am

VistaGen Therapeutics, Inc. (VSTA) Uses Stem Cells to Build a Better Scientific Model for Drug Development

Why do pharmaceutical drugs cost so much? Because pharmaceutical companies waste so much money and time developing them. But these companies can be excused for wasting hundreds of millions of dollars and years of work developing drugs that won’t be approved for use. The conventional method for initially testing the effectiveness and toxicity of these drugs – testing on animals – is terribly ineffective. While scientific models like animals can provide a clue of how a drug might affect a human, they can never truly replicate the effects of giving the drug to people. Drugs that might not work in…

WednesdayMar 27, 2013 10:42 am

VentriPoint Diagnostics Ltd. (VPTDF) Offers New Hope for CHD Patients

One of the challenges facing heart doctors is working with people having congenital heart disease (CHD). It’s a growing problem that involves unique issues. Though CHD is usually associated with children, a recent article by Michael O'Riordan in Clinical Cardiology (http://dtg.fm/5AjT) references a report indicating that the frequency of hospitalizations among adults for congenital defects has grown twice as fast as for children, with annual adult admissions now over a third of total CHD admissions. Among other factors, people who used to die young from such problems are now often living well into adulthood. The result is a growing burden…

WednesdayMar 27, 2013 10:34 am

Viscount Systems Inc. (VSYS) Revolutionary Security Products

Viscount has been controlling facility access for over 30 years, but has today become a leader in the application of advanced IT technology to physical access. The foundation for this revolution is the company’s MESH Security Operating Platform, designed to reduce the complexity and cost of facility protection through the replacement of traditional hardware with IT servers and accessories. The result is more security for less money. The MESH platform is able to manage a large array of card access, intercom, video, and other devices, by using a common interface layer, and provides a critical and flexible foundation for Viscount…

WednesdayMar 27, 2013 10:13 am

Liquidmetal Technologies Inc. (LQMT) Video Chart for Wednesday, March 27, 2013

LQMT has found support levels at 7.6 cents and 8 cents. In the past month the chart has made two higher highs and climbed back over the 50-day simple moving average, putting it on technical watch to potentially test the highs at 11.4 cents again. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

WednesdayMar 27, 2013 10:07 am

UQM Technologies, Inc. (UQM) Powers Audi Test Expansion

UQM Technologies announced that the company will be providing the systems that Audi will be testing in its A1 e-tron extended range electric vehicles. UQM's PowerPhase systems will be used in testing that will occur through 2013 in Germany's National Platform of Electrification; the NPE is promoting this program to demonstrate and further develop the viability of electric vehicles. Longmont, CO-based UQM is focused on developing and manufacturing power-dense, high-efficiency electric motors, generators and power electronic controllers for the automotive, commercial truck, bus, marine, and military markets. In addition, UQM is developing propulsion systems for electric, hybrid electric, plug-in hybrid…

WednesdayMar 27, 2013 9:00 am

OxySure Systems, Inc. (OXYS) Taps into Diverse Expertise of New Independent Director Jerry Jones

OxySure® Systems, a medical device innovator of emergency oxygen solutions, has named Jeremy M. ("Jerry") Jones, former chairman and CEO of Apria Healthcare, as an independent director effective April 1, 2013. During his more than 35 years of experience in the healthcare industry, Jones has led healthcare industry coalition efforts; served two terms as chairman of the Health Industry Distributors Association (HIDA); was a board member of the National Association of Medical Equipment Services; and was founding chairman of the Home Oxygen Services Coalition. He received the Dr. Jonas Salk Memorial Mentor in Medicine Award from the March of Dimes,…

WednesdayMar 27, 2013 8:27 am

International Stem Cell Corp. (ISCO) Reports 2012 Financial Results and Updates Investors

International Stem Cell Corp., a biotechnology company focused on therapeutic and biomedical products using human parthenogenetic stem cells (hpSCs), announced its financial results for the three and twelve months ended December 31, 2012. FY 2012 Highlights: • Made significant progress in Parkinson's program including the development of a new highly-efficient manufacturing method for generating neuronal cells and conducted preliminary toxicology and pharmacology studies in animals. • Added world-recognized neurobiologist, Dr. Evan Y. Snyder, head of the FDA's Cellular, Tissue and Gene Therapies Advisory Committee, Director of the Stem Cells and Regenerative Biology Program at Sanford Burnham Medical Research Institute, as…

Site Search

Company Search

Month: March 2013